Teladoc Health, Inc.TDOCNYSE
Loading
Revenue Growth Recovery in ProgressRecovering
Percentile Rank33
3Y CAGR-16.3%
5Y CAGR-40.1%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
-16.3%/yr
vs -9.3%/yr prior
5Y CAGR
-40.1%/yr
Recent acceleration
Acceleration
-7.0pp
Decelerating
Percentile
P33
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 2.53% |
| Q3 2025 | -0.86% |
| Q2 2025 | 0.40% |
| Q1 2025 | -1.74% |
| Q4 2024 | -0.00% |
| Q3 2024 | -0.30% |
| Q2 2024 | -0.57% |
| Q1 2024 | -2.18% |
| Q4 2023 | 0.04% |
| Q3 2023 | 1.20% |
| Q2 2023 | 3.68% |
| Q1 2023 | -1.33% |
| Q4 2022 | 4.30% |
| Q3 2022 | 3.21% |
| Q2 2022 | 4.78% |
| Q1 2022 | 2.01% |
| Q4 2021 | 6.24% |
| Q3 2021 | 3.68% |
| Q2 2021 | 10.90% |
| Q1 2021 | 18.35% |
| Q4 2020 | 32.72% |
| Q3 2020 | 19.82% |
| Q2 2020 | 33.31% |
| Q1 2020 | 15.53% |
| Q4 2019 | 13.42% |
| Q3 2019 | 5.91% |
| Q2 2019 | 1.32% |
| Q1 2019 | 4.75% |
| Q4 2018 | 10.62% |
| Q3 2018 | 17.35% |
| Q2 2018 | 5.48% |
| Q1 2018 | 16.21% |
| Q4 2017 | 12.37% |
| Q3 2017 | 53.95% |
| Q2 2017 | 3.95% |
| Q1 2017 | 14.70% |
| Q4 2016 | 15.50% |
| Q3 2016 | 22.25% |
| Q2 2016 | -1.49% |
| Q1 2016 | 18.77% |